CIK 0001711754
- Non-accelerated filer
- Smaller reporting company
Inmune Bio, Inc.
Sign in to watch- Ticker
- INMB
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- NV
- Entity type
- Operating
- EIN
- 475205835
- Phone
- +1 858-964-3720
- Business address
- 225 NE MIZNER BLVD, SUITE 640, BOCA RATON, FL, 33432
- 4 Open-market buy President and CEO bought 6,300 shares at $6.41 ($40,383)
- 4 Open-market buy CFO, Treasurer & Secretary bought 10,700 shares at an average $6.42 ($68,649)
- 4 Grant or award Chief Scientific Officer acquired 23,590 shares (grant or award)
- 4 Grant or award President and CEO acquired 23,724 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award CFO, Treasurer & Secretary acquired 17,793 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Grant or award Director acquired 17,793 shares (grant or award)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 2,500 shares at $13.55 ($33,875)
- 4 Open-market sale Chief Scientific Officer sold 701 shares at $20.00 ($14,020)
- 4 Open-market sale CFO, Treasurer & Secretary sold 1,025 shares at $20.00 ($20,500)
- 4 Open-market sale President and CEO sold 3,626 shares at $20.00 ($72,520)
- 4 Open-market sale President and CEO sold 6,517 shares at $20.00 ($130,340)
- 4 Open-market sale Chief Scientific Officer sold 2,357 shares at $20.00 ($47,140)
- 4 Open-market sale CFO, Treasurer & Secretary sold 2,079 shares at $20.00 ($41,580)
- 4 Open-market sale President and CEO sold 23,616 shares at $20.00 ($472,320)
- 4 Open-market sale CFO, Treasurer & Secretary sold 1,155 shares at $20.00 ($23,100)
- 4 Open-market sale Chief Scientific Officer sold 400 shares at $20.00 ($8,000)
Page 4 of 8 · 142 filings